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Ever tried, ever failed. No matter. Try again. Fail again. Fail better. 
(Samuel Beckett) 
 
 
 
 
 
  
 ABSTRACT 
In recent years, concerns have been raised regarding the potential negative 
impact of anesthetic drugs in postoperative cognitive dysfunction. This 
thesis is an attempt to contribute to the understanding of the underlying 
mechanisms. Previous animal studies have suggested that volatile 
anesthetics can cause long-lasting cognitive alterations in various settings. 
Based on the strong association between cholinergic function and 
cognitive performance, we have focused our studies on the long-term 
effects of volatile anesthetics on cholinergic neurotransmission.  
 
By using a combination of laboratory animal experiments and molecular 
biology techniques in cultured cells, we have described effects of 
sevoflurane anesthesia on cognitive function and cholinergic signaling. 
Our studies on spontaneous exploratory behavior, anxiety, object memory 
and analyses of behavioral organization in mice show that for some 
aspects of cognitive performance sevoflurane can cause long-lasting 
effects, while other aspects are unaltered by anesthesia. We have shown 
that age and preexisting cholinergic dysfunction are factors that influence 
the results. A normal cholinergic system, as represented by young wild 
type mice, seems to protect from behavioral alterations after anesthesia.  
 
Our results suggest that sevoflurane causes a sustained attenuation in 
acetylcholine-induced phosphorylation of important intracellular kinases. 
We have linked our findings to signaling via muscarinic acetylcholine 
receptors, and we have also demonstrated that the effect of sevoflurane is 
not likely exerted by reducing the receptor population on the cell surface, 
nor by altering the total amount of receptor protein available for ligand 
binding.  
 
The overall conclusion from the results of this thesis is that under certain 
experimental conditions, sevoflurane induces long-lasting alterations both 
in animal behavior and in cellular signaling. 
 
 
 
 
Key words: Postoperative cognitive dysfunction, sevoflurane, 
acetylcholine, nicotinic acetylcholine receptors, muscarinic acetylcholine 
receptors, anesthesia, episodic-like memory, spatial memory 
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INTRODUCTION 
 
BACKGROUND: 
In recent years, a gradually increasing attention among anesthesiologists has 
been directed to cognitive deficits, such as learning or memory impairment, 
which might occur in patients after surgery. Recent studies have 
demonstrated that as many as 26% of patients show measurable degrees of 
cognitive deterioration at one week after surgery, and that 10% of patients 
still show cognitive deficits three months later (Moller, Cluitmans et al. 
1998). These particular cognitive deficits in which there is a temporal 
relation between surgical intervention and cognitive problems are 
denominated postoperative cognitive dysfunction (POCD).  
 
According to official statistics from the National Board of Health and 
Welfare (Socialstyrelsen), a total of 1108627 patients underwent surgery in 
Sweden in 2009 alone. With a growing number of surgical procedures 
performed each year, together with an increasingly elderly population, the 
number of people presenting with POCD will also likely increase. 
 
This thesis project emanates from the questions surrounding this 
phenomenon, and was conceived in an attempt to shed some light on one of 
the most crucial questions, namely the role of anesthesia drugs for the 
development of POCD. Thus, in an attempt to contribute with some of the 
highly sought for pieces of the mechanistical puzzle of POCD, we have 
addressed the question of measurable and reproducible long-term effects on 
cholinergic signaling and cognitive function. 
 
POSTOPERATIVE COGNITIVE DYSFUNCTION (POCD) 
Early on in the history of anesthesia, concerns were raised on the potential 
drawbacks from anesthetic agents, and that there would be negative aspects 
of exposure to anesthesia as well. In a seminal paper by Bedford in the 
Lancet in 1955 (Bedford 1955), several case descriptions of cognitive 
dysfunction accompanied his hypothesis that anesthetic drugs might be one 
of the factors causing the problem.   
 
With the development of cardiac surgery and the use of extracorporeal 
circulation techniques, there was also an increased concern for the cognitive 
problems that seemed to be associated with this specific type of surgery 
(Willner, Rabiner et al. 1976; Shaw, Bates et al. 1987; Mills 1993). For a 
long time, cognitive problems after cardiac surgery were attributed to the 
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specific situation of by-pass circulation, with microemboli as the most 
common and likely culprit. However, since cognitive deficits were also 
observed in patients undergoing non-cardiac surgery, the question of 
underlying mechanisms was soon open again.  
 
In 1998, a large multicenter study by Moller and coworkers, demonstrated 
that as many as 26% of patients undergoing non-cardiac surgery would 
present measurable cognitive deficits at one week postoperatively, and that 
10% of patients would still show cognitive deficits at three months after 
surgery (Moller, Cluitmans et al. 1998). Several studies followed, and in 
2008, Monk and co-workers presented even higher numbers of POCD at 
hospital discharge. In their study, POCD was present in as many as 41.4% of 
elderly (60 years and older), in 30.4% in middle-aged (40 to 59 years) and in 
36.6% in young (18 to 39 years) patients, when measured at 1 week after 
surgery. At three months after surgery, POCD was still present in 5.7% of 
young patients, in 5.6% of middle-aged patients, and in 12.7% of elderly 
patients (Monk, Weldon et al. 2008). A list of selected studies on the 
incidence of POCD in non-cardiac surgery is presented in table 1.  
 
It has even been stated that POCD would be associated with increased 
mortality, risk of leaving the labor market prematurely and that it would lead 
to increased dependency on social transfer payments (Johnson, Monk et al. 
2002; Rudolph, Jones et al. 2007; Monk, Weldon et al. 2008; Steinmetz, 
Christensen et al. 2009). Taken together, this translates to a substantial cost 
for postoperative delirium and cognitive dysfunction (Deiner and Silverstein 
2009; Steinmetz, Christensen et al. 2009). 
 
In summary, there is overwhelming documentation that POCD does indeed 
exist (Perouansky and Hemmings 2009). Nevertheless, since it often 
presents itself only as a subtle persistent deterioration in cognitive 
performance after a surgical intervention, in clinical reality, it can be difficult 
to diagnose and is therefore quite often foreseen (Maze and Todd 2007).  
 
Table 1: Incidence of postoperative cognitive dysfunction in patients (modified from 
Newman et al 2007): 
Study POCD at 1 week (%) POCD at 3 months (%) 
Moller, Cluitmans et al. 1998 25.8% vs. 3.4%  9.9% vs. 2.8%  
Dijkstra, Houx et al. 1999 27% vs. 6% 8% vs. 2% (NS) 
Rasmussen and Moller 2000 32.7% vs. 3.4 9.4% vs. 2.8% 
Ancelin, de Roquefeuil et al. 
2001 
71% (no control) 56% (no control) 
Jonsson et al, 2002 19.2% vs. 4.0% 6.2% vs. 4.2% (NS) 
Monk et al, 2008 30-41% vs. 2.8-5.1% 16-39% vs. 6.3% 
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Risk factors for POCD 
Insofar, the major risk factors associated with the development of POCD 
seem to be high age, low educational level, history of previous cerebral 
vascular accident and the presence of cognitive dysfunction at hospital 
discharge (Ancelin, de Roquefeuil et al. 2001; Monk, Weldon et al. 2008). 
Also, preexisting cognitive dysfunction prior to surgery seems to be of 
importance (Silverstein, Steinmetz et al. 2007; Bekker, Lee et al. 2010).  
 
In addition, medical conditions such as alcohol abuse (Hudetz, Iqbal et al. 
2007; Hudetz, Patterson et al. 2009) thyroid disease have also shown to 
affect the risk panorama (Newfield 2009) as has metabolic syndrome. 
Cortisol levels have been suggested to be associated with POCD 
(Rasmussen, O'Brien et al. 2005; Pearson, de Vries et al. 2010). Recently, 
preoperative depression and poor executive function were presented as two 
independent risk factors (Smith, Attix et al. 2009). 
 
Furthermore, surgical trauma, inflammation, postoperative pain, analgesic 
regimen and many other associated factors seem to play a non-negligible 
part in the development of POCD. (Newfield 2009) A recent study has 
shown that differences in cognitive performance is much more strongly 
related to the surgical intervention than to the type of anesthetic regimen 
used (Ancelin, de Roquefeuil et al. 2010).  
 
Table 2: Risk factors associated with POCD at 3 months after surgery. 
Probable Possible Not likely 
Advanced age Opioid treatment ICU-stay 
Low educational level Proinflammatory mediators Hypercapnia 
POCD at discharge Cortisol secretion Hypoxia 
Previous stroke Pain Hypotension 
Preop cognitive impairment Psychological factors  
Preoperative depression Anesthesia  
 Surgical category  
 
Proper analgesic treatment seems to be protective of POCD (Morrison, 
Magaziner et al. 2003) after hip replacement surgery. Also analgesic 
adjuvant therapy with the NMDA-receptor antagonist ketamine seems to be 
protective following coronary artery bypass surgery (CABG) surgery 
(Hudetz, Iqbal et al. 2009). The use of regional anesthetic techniques is 
advocated in patients with cognitive decline prior to surgery (Halaszynski 
2009). In CABG patients, a recent study has shown an increase in amyloid 
proteins and an association with cognitive decline similar to that of 
Alzheimer’s disease (Evered, Silbert et al. 2009). A recent study in non-
cardiac surgery patients has demonstrated a robust postoperative 
neuroinflammatory response, with striking similarities to the inflammatory 
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pattern seen in Alzheimer patients. Even more interesting, their results 
suggest that anesthetic management could be of relevance for modulating 
this response (Tang, Baranov et al. 2011). 
 
Cognitive function:  
”Cogito, ergo sum*” Descartes famous words on how thinking proves our 
existence are a good introduction to cognition. Descartes gave his view on 
thinking in his work ”Les principes de la philosophie”, which was published 
in 1644: 
  
“Par le mot de penser, j’entends tout ce qui se fait en nous de telle sorte que nous 
l’apercevons immédiatement par nous-mêmes ; c’est pourquoi non seulement entendre, 
vouloir, imaginer, mais aussi sentir, est la même chose ici que penser. “** 
 
The word “cognition” is derived from the latin word cognoscere, which 
means ”to know” or “to think”. In general terms, cognition is the collective 
awareness and the integration of sensory inputs from all organs into our 
conscious awareness of our surroundings. It also incorporates learning, 
memory, logic thinking, verbal fluency, communication skills and many 
more aspects of brain function. This makes the term difficult to easily define, 
and thus makes it elusive when it comes to how it should be measured and 
quantified. The results of testing cognitive function will be highly dependent 
on which aspect of cognitive function is being studied (Newman, Stygall et 
al. 2007) and is also highly dependent on the context in which it is tested.  
 
Therefore, most studies on POCD have used various neuropsyhological test 
batteries covering several aspects of cognitive function, in order to assess the 
global level of cognitive function. The term POCD infers a temporal relation 
to surgery in which the cognitive decline is preceded by a surgical 
procedure. Furthermore, the diagnosis requires a comparison between the 
cognitive performance prior to and following the intervention in order to 
discern the contribution to the cognitive decline by the surgical procedure 
itself.  
 
For the purpose of evaluating and comparing data, most studies rely on 
comparing the Z score, as described in the International Study of 
Postoperative Cognitive Dysfunction (ISPOCD) study by Moller et al 
(Moller, Cluitmans et al. 1998).  
 
*”I think, therefore I am” 
**“By the word thinking, I intend everything that is perceived by ourselves; that is why 
not only hearing, wanting, imagining, but also feeling is the same thing as thinking” 
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Several separate cognitive function tests are summarized to a composite Z 
score, which is used to assess global cognitive change (Monk, Weldon et al. 
2008). A negative change in cognition, when significant, is now commonly 
referred to as postoperative cognitive dysfunction (POCD) (Deiner and 
Silverstein 2009). 
 
The most commonly used tests can be grossly divided into two groups, of 
which the first includes tests aiming at evaluating executive function. Tests 
aiming at assessing concentration, processing speed and attention would fall 
into this category. Examples of such tests are the Stroop color-word test, 
Concept shifting task and the Letter-digit coding test. Into the second 
category would fall tests aiming at assessing learning and memory such as 
Visual verbal learning test with immediate and delayed recall of words.  
 
One of the domains of cognitive function most susceptible to 
neurodegenerative diseases, such as Alzheimer’s disease, is the episodic 
memory (Belleville, Sylvain-Roy et al. 2008). This can be characterized as 
explicit memory of information on what, when and where, and also as a 
contextual memory of the relationships between these variables. In animal 
studies it is most commonly referred to as episodic-like memory.  
 
Although at a first glance somewhat similar, postoperative delirium and 
postoperative cognitive dysfunction are regarded as two separate entities 
(Rudolph, Jones et al. 2007; Rudolph, Marcantonio et al. 2008; Deiner and 
Silverstein 2009; Robinson, Raeburn et al. 2009). The definition of delirium 
as described in the Diagnostic and Statistical Manual of Mental Disorders 
fourth edition (DSM-IV) points out the following main characteristics for the 
diagnosis: First, a change in mental status involving reduction of the 
awareness of the environment and disturbances in attention. Second, 
hallucinations or cognitive symptoms such as disorientation and memory 
deficits often occur.   
 
Links between general anesthesia and POCD 
Still today, more than one and a half century after the introduction of general 
anesthesia, the underlying mechanisms are not fully understood. To the 
layman, anesthesia is often explained as a state of unconsciousness or sleep. 
But, it is also a state of amnesia, analgesia and immobility. Most commonly 
general anesthesia is achieved using a combination of drugs providing each 
of the desired qualities; anesthetics for unconsciousness and amnesia, 
opioids or local anesthetics for analgesia, and muscle relaxants for 
immobility. It is often noted in the clinical setting that although the patient 
has regained full consciousness after anesthesia, amnesia can still be most 
Andreas Wiklund   
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present. This postoperative amnesia has been attributed residual effects of 
anesthetics, and might last several hours following anesthesia.  
 
General anesthetics fall into one of two categories. First, there are the 
volatile anesthetic agents, such as sevoflurane, isoflurane and desflurane, 
which are generally used to maintain anesthesia and more rarely used for 
induction. Second, there are the intravenous agents, such as propofol or 
barbiturates, which are most commonly used for induction of anesthesia, 
rather than maintenance. Although some compounds share similar features 
with respect to receptor affinity in the central nervous system, it is intriguing 
to realize how such a wide range of chemically very diverse compounds can 
cause a virtually identical effect when it comes to altering the level of 
consciousness.  
 
Anesthetics are believed to act via inhibiting transmission via excitatory 
receptors and potentiating transmission via inhibitory receptors. Although 
some anesthetic agents display narrow receptor affinities, e.g. propofol, 
which acts mainly on inhibitory GABAA receptors, others, e.g. volatile 
anesthetics such as sevoflurane, display promiscuous receptor affinities, 
binding to a large population of structurally diverse receptors. (Campagna, 
Miller et al. 2003) Anesthetics thus interact with neurotransmitter release, 
excitability of neuronal membranes, and by affecting signaling in key brain 
structures, the state of unconsciousness is reached. The exact 
neurobiochemical processes leading to this state are still to date not fully 
elucidated ((Campagna, Miller et al. 2003; Grasshoff, Rudolph et al. 2005; 
Franks 2008).  
 
Sevoflurane 
Sevoflurane (1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane) is one of the 
most commonly used volatile anesthetics worldwide. It is a highly 
fluorinated methyl isopropyl ether, with a boiling point of 58.6°C and a 
molecular weight of 200g/M. Like most volatile anesthetics, the mechanism 
of action is unclear, but likely mediated by effects on a wide array of 
receptors, among which can be mentioned potentiation of GABAAR, 
glycineR, and potassium channels, and simultaneous inhibition of nAChR, 
mAChR, NMDAR, AMPAR, serotoninR and voltage gated sodium channels 
(Alkire, Hudetz et al. 2008) 
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ANIMAL AND CELLULAR MODELS OF POCD 
It is possible to grossly divide animal models for cognitive function into two 
categories:  conditioned and unconditioned tests. The first category of tests 
all use some form of reinforcer, either as reward or punishment, as a means 
of increasing the sensitivity of the test. Unconditioned tests do not require 
reinforcers. Instead, they rely on the natural and spontaneous behaviors of 
the animal, and are considered more sensitive to subtle changes in behavior 
than conditioned tests (Ennaceur and Delacour 1988). 
 
Several studies in rats have shown persistent memory and learning 
difficulties following general anesthesia. The effects outlast by far what 
would be predicted from the pharmacokinetic profile of the investigated 
compounds (Culley, Baxter et al. 2003; Culley, Baxter et al. 2004; Crosby, 
Culley et al. 2005). It seems that type of compound also matters, for example 
did not propofol alter spatial cognitive performance in aged rats (Lee, Culley 
et al. 2008). Although most studies point at long-lasting effects, lasting days 
to weeks, of exposure to anesthetics, not all indicate that learning and 
memory is impaired. Some even demonstrate improved spatial learning after 
exposure to volatile anesthetics (Komatsu, Nogaya et al. 1993; Komatsu, 
Nogaya et al. 1998; Butterfield, Graf et al. 2004; Rammes, Starker et al. 
2009) 
 
There are some conflicting findings on anesthetic exposure and neurotoxicity 
in vivo and in vitro. In rats, in which behavioral alterations might last for 
several weeks, no increase in cell death in brain regions has been observed 
after general anesthesia with isoflurane (Stratmann, Sall et al. 2010). In 
contrast, others have demonstrated that prolonged (6h) exposure to 
isoflurane induces caspace pathways and increases apoptosis in brain cells 
(Xie, Dong et al. 2006). Another cause for concern with respect to anesthetic 
involvement in POCD is the finding that volatile anesthetics, again in 
contrast to propofol, seem to be linked to enhanced aggregation and toxicity 
of the Alzheimer disease-associated amyloid beta protein (Eckenhoff, 
Johansson et al. 2004; Xie, Dong et al. 2006). In relation to this, an increased 
interest has been directed against the connection between neuroinflammation 
and cognitive deterioration (Caza, Taha et al. 2008; Xie, Zhang et al. 2009; 
Hu, Ou et al. 2010; Hudetz, Patterson et al. 2011).  
 
The effects of anesthetics seem to be more pronounced in aged animals. A 
recent study has shown astrocytosis, increased beta-amyloid protein and 
increased phosphorylation of tau in aged mice subjected to general 
anesthesia and surgery. (Wan, Xu et al. 2010). 
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Adding surgery to the scene makes the image even more complex since pro-
inflammatory cytokines seem to have a strong influence on cognitive 
function (Terrando, Rei Fidalgo et al. 2010). Proinflammatory cytokine 
dependent activation of glial cells increase neuroinflammation (Wan, Xu et 
al. 2007). In fact, in operated rats, anesthesia technique has showed to be of 
less importance than the type of surgical trauma (Cao, Ma et al. 2010).  
 
In conclusion, animal studies support the assumption that anesthetics induce 
long-lasting physiological changes, which can be observed as alterations in 
cognitive performance. These deficits are often noted in functions such as 
memory, attention and speed of information processing, areas, which are 
closely related to the actions of cholinergic neurotransmission. This will be 
further explored in the next chapter.  
 
CHOLINERGIC NEUROTRANSMISSION 
In 1926 Otto Loewi performed an experiment where he demonstrated that 
the vagus nerve signaled though a water-soluble compound first described as 
“vagusstoff“, but soon characterized as acetylcholine. Ten years later, Otto 
Loewi and Henri Dale, were rewarded the Nobel Prize in Physiology or 
Medicine “for their discoveries relating to the chemical transmission of nerve 
impulses”. Acetylcholine was thus the first neurotransmitter to be described 
(Tansey 2006).  
 
Distribution of cholinergic neurons 
As a neurotransmitter, acetylcholine acts at multiple targets in the central and 
peripheral nervous system, in the neuromuscular junction, in the visceral 
motor system and also functions as a modulator of the immune system 
(Wessler and Kirkpatrick 2008; Rosas-Ballina and Tracey 2009). Although 
cholinergic neurons comprise less than one percent of neurons in the central 
nervous system, they are involved in a wide range of neural functions due to 
their widespread distribution in the brain. As illustrated in figure 2, virtually 
every part of the brain receives projections from cholinergic neurons, which 
extend over long distances. An interesting feature about the distribution of 
cholinergic neurons is how it interacts in a relatively consistent manner of 
motor versus sensory, which topographically translates to a ventral to dorsal 
orientation of projections in both the brain and the spinal cord (Woolf and 
Butcher 2010). From the basal forebrain population of cholinergic neurons 
widespread projections reach almost the entire cortex. These neurons are 
believed to play a central role in selective attention, learning, memory, 
perception and consciousness (Woolf and Butcher 2010). Ascending 
cholinergic neurons originating in the mesopontine region and projecting to 
prefrontal and other cortical areas also play an important role in higher 
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cognitive performance in rodents (Wuppen, Oesterle et al. 2010). Currently, 
cholinergic receptor agonists or allosteric modulators are being tested as 
therapeutics (Hurst, Hajos et al. 2005). Moreover, pharmacological 
modulation of both nicotinic and muscarinic cholinergic functions in various 
psychiatric disorders can modify cognitive function and reduce symptoms 
(Araki, Suemaru et al. 2002; Poirier, Canceil et al. 2002; Newhouse, Singh et 
al. 2004).  
 
As previously mentioned, cholinergic neurotransmission is involved in 
attention, but also in particular aspects of learning and memory processes, 
and especially in the encoding of new memories. During learning of a new 
task, acetylcholine levels are highest in the beginning of the learning period, 
and gradually become lower with habituation. A biphasic role for 
acetylcholine in learning and memory has also been demonstrated, in which 
high levels of acetylcholine are necessary for encoding, but where low levels 
of acetylcholine facilitate retrieval of memories. Acetylcholine has thus been 
proposed to set the brain in a recording mode, rather than a playback mode, 
when it comes to learning and memory (Hasselmo and Sarter 2011). 
Cholinergic signaling via mAChRs has been indeed been shown to be 
important to the consolidation of new memories, but of less importance in 
the retrieval of already stored memories (Warburton, Koder et al. 2003). In 
addition, acetylcholine signaling is necessary for cellular plasticity and the 
formation of new synapses necessary for learning (Woolf and Butcher 
2010).  
 
Anesthesia and cholinergic signaling 
There are several interesting links between the cholinergic system and the 
action of anesthetics. Several different volatile anesthetics have shown to 
affect cholinergic signaling in vitro (Franks and Lieb 1994; Violet, Downie 
et al. 1997; Flood and Coates 2002; Tassonyi, Charpantier et al. 2002; 
Chiara, Dangott et al. 2003). In vivo experiments have demonstrated that 
isoflurane reduces acetylcholine release in the brain (Dong, Fukuda et al. 
2006), and that this effect is even more pronounced in aged animals 
(Jansson, Olin et al. 2004). Interference with prefrontal mAChRs can 
significantly alter arousal from anesthesia (Dennison, Anthony et al. 1987; 
Demarco, Baghdoyan et al. 2004). Since, cholinergic neurons are believed to 
contribute to the complex regulation of the oscillations in the brain that 
regulate sleep-wake cycles, contribute to perception and are involved in the 
global synchronization of brain functions (Woolf and Butcher 2010) it has 
been suggested that cholinergic neurotransmission is involved in the 
regulation of consciousness.  
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Acetylcholine receptors 
The subtypes of neuronal acetylcholine receptors are divided into nicotinic 
acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors 
(mAChRs), as illustrated in figure 3. Nicotinic AChRs are ligand-gated ion 
channels composed of five transmembranous subunits of which there are 
nine different α-subunits (α2- α10) and three β-subunits (β2-β4) (Wevers 2010) 
The most common types of nAChR in the central nervous system are the α7 
and the α4β2 subtypes. While α4β2 are widely distributed over the entire brain, 
α7 are mainly located in hippocampus, amygdala, hypothalamus and 
restricted layers of the cerebral cortex (Graef, Schonknecht et al. 2011).  
 
Table 3: Major acetylcholine receptor subtypes 
Receptor  Type Localisation Effector 
M1 Muscarinic Cortex, Hippocampus Gq-coupled, IP3 
M2 Muscarinic Brainstem, thalamus, cerebellum Gi-coupled, cAMP 
M3 Muscarinic Enteric NS, CNS Gq-coupled, IP3 
M4 Muscarinic Striatum Gi-coupled, cAMP 
M5 Muscarinic Substantia nigra Gq-coupled, IP3 
7 Nicotinic Hippocampus, amygdala Ca2+ influx 
 Nicotinic Widespread in CNS Na+-influx 
 
Nicotinic AChRs are ion channels with different selectivity for cations. The 
homomeric α7-nAChR is highly selective for Ca2+ ions, whereas the 
heteromeric α4β2-receptor is a Na+ selective channel. Thus activation of α7-
nAChR act excitatory, and activation of α4β2-nAChRs modulate membrane 
potential and increases excitability. While ionotropic nAChRs mediate fast 
synaptic transmission, the metabotropic mAChRs are G protein-coupled and 
mediate slower responses, lasting seconds to minutes. 
 
Classification of G proteins is made based upon the subunit composition, of 
which there are four types: Gs, Gi, Gq and G12/13. It is thus the receptor-
associated G protein that determines the nature of the response upon agonist 
binding to the receptor. Receptor-induced activation of Gs proteins 
stimulates adenylyl cyclase activity, opens Ca2+-channels and closes Na+-
channels. mAChRs belong to either Gq (M1, M3, M5), or Gi (M2, M4). The Gi 
family inhibits adenylyl cyclase, closes Ca2+-channels and opens K+-
channels. Activation of Gq leads to increased activity in phospholipase C and 
IP3/DAG, which in turn regulates intracellular Ca2+-signaling. G12/13 proteins 
are involved in cytoskeletal remodeling, via Rho family GTPase signaling 
(Minami and Uezono 2006) 
 
Of the different mAChR subtypes, M1 receptors are the most abundant 
subtype in cortex and hippocampus and are believed to be involved in 
cognition and neuroinflammation (Fisher, Pittel et al. 2003). M2 receptors 
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also obstruct the lumen, as is the case for nAChRs and volatile anesthetics 
(Flood et al. 2008). This has been repeatedly demonstrated for both ligand 
gated ion channels (Raines, Rankin et al. 1995; Raines 1998; Raines and 
Zachariah 1999) as well as for metabotropic receptors, such as mAChRs 
(Forman, Miller et al. 1995; Durieux 1996; Nietgen, Honemann et al. 1998; 
Weigl and Schreibmayer 2001). Anesthetics can also competitively inhibit 
the function of a protein, as for the protein firefly luciferase, in which 
anesthetics competitively block substrate binding to the enzyme (Franks and 
Lieb 1984; Franks, Jenkins et al. 1998; Eckenhoff, Tanner et al. 2001). 
Overall, a common feature of anesthetics seems to be that they enhance 
signaling via inhibitory receptors and impair signaling mediated via 
excitatory receptor systems. 
 
Intracellular signaling pathways related to acetylcholine receptors 
On of the most extensively studied intracellular pathways is the Mitogen 
Activated Protein Kinase (MAPK)-pathway. Here, an extracellular signal is 
relayed down from the receptor via a series of kinases down to a 
Extracellular Signal Regulated Kinase (ERK), of which there are several 
isoforms. The most extensively studied isoforms are ERK 1/2. 
Phosphorylation of ERK 1/2 activates the enzyme, which in turn leads to 
alteration of transcription factors such as CREB, cFos, and others.  
 
Another pathway of interest is the one involving PI3K/AKT and mTOR. 
Activation of AKT or PKB, as it also called, can come from multiple 
sources, of which G protein-coupled receptors is one alternative. The AKT 
pathway is believed to be involved in cell survival and apoptosis. In 
oncology, this signaling pathway has received major interest since many 
tumor cells have constantly active AKT, and might depend on this for 
survival. More of relevance to this thesis is that exposure to volatile 
anesthetics increase phosphorylation of AKT, which in this context has been 
implicated in the long-lasting effects of pharmacological cardiac 
preconditioning (Wang, Traystman et al. 2008).  
 
There are also other signaling pathways originating from G proteins, such as 
the PI3K/AKT pathway. Having listed these different pathways, it is 
important also to note that considerable crosstalk between different signaling 
pathways occurs when converging pathways share the same effector proteins 
or transcription factors. 
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AIMS OF THE THESIS: 
 
The overall aim of this thesis was to evaluate the effects of sevoflurane 
anesthesia on cognitive function and cholinergic signaling.  
 
The specific aims were:  
 
I: To investigate sevoflurane-induced alterations of exploratory and anxiety-
like behavior in young and aged mice with a pre-existing nicotinic 
cholinergic dysfunction.  
 
II: To investigate the effect of sevoflurane anesthesia, age and pre-existing 
nicotinic cholinergic dysfunction on object memory. 
 
III: To describe the effects of sevoflurane exposure on long-term alterations 
in cholinergic signaling and intracellular pathways.  
 
IV: To investigate if sevoflurane exposure alters cellular acetylcholine 
receptor surface expression, gene transcription or amount of receptor 
proteins.  
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MATERIALS AND METHODS:  
Animals 
For the behavioral studies in paper I and II we used C57BL/6 mice, both 
wild type and genetically modified mice. The genetically modified mice 
were deficient of the gene for the β2 nAChR subunit. They displayed a 
distinct behavioral phenotype with hyperactivity, abnormal social behavior, 
but with preserved spatial learning (Picciotto, Caldarone et al. 2001) 
(Granon, Faure et al. 2003). Young mice were 3-4 months of age. Aged mice 
were 15-18 months of age at the time of experiments. In total 30 young wild 
type, 20 aged wild type, 28 young β2KO and 22 aged β2KO-mice were used 
for the experiments in paper I and II.  
 
Anesthesia  
For anesthesia, animals were placed in a small plexiglass cylinder, into 
which a mixture of oxygen and sevoflurane was fed via nylon tubing. 
Temperature control was achieved via external heating, and animal body 
temperature was monitored continuously via a rectal thermometer. 
Respiratory rate was monitored every five minutes during anesthesia.  
In a series of pilot animals prior to the study in paper I, it was determined 
that sevoflurane at 2.6% was a suitable concentration, at which the 
respiratory rate was sufficient to prevent hypoxia. Blood oxygen saturation 
was continuously monitored with a neonatal pulse oximetry probe, but only 
in the pilot animals. This was due to technical issues on attaching the probe 
to the thigh of the mouse without affecting spontaneous locomotion 
afterwards.  
 
Open field 
A common way of analyzing rodent behavior is to study movements in an 
open field (Ammassari-Teule, Fagioli et al. 1994). In our studies we used a 
circular open field to investigate both spontaneous exploratory activity and 
anxiety in the animal. The trajectories of the mice in the open field were 
recorded using an automated video tracking system. Based upon movement 
velocity, the information was broken down into navigatory or exploratory 
behavior. An index, called exploratory index, was calculated by dividing the 
time spent in slow exploration with the time spent in fast navigation.  
Further analysis of the way the mice organized their trajectories and their 
behavior was made by dividing the behavior into active (A) or inactive (I) 
periods, and also dividing the location of the animal into central (C) or 
peripheral (P) relating to the position within the circular open field. Thus, a 
two-letter code (CA, CI, PA or PI) could be attributed to the animal behavior 
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at every time-point during the experimental session. By further analyzing the 
sequence of codes we were able to compare patterns of behavioral 
organization. Since our aim was to detect subtle changes in animal behavior, 
we believed that unconditioned tests of normal exploratory behavior would 
be the most sensitive and most suitable for our hypotheses. The details of the 
experimental procedure are available in the materials and methods section in 
paper I.  
 
Elevated plus maze 
Although the open field test gives some information on anxiety levels, as 
expressed in time avoiding the central part of the open field, the elevated 
plus maze test aims more specifically at evaluating anxiety-like behavior 
(File 2001). This test consists of a cross-shaped platform, with two arms 
with walls (closed arms) and two without (open arms), and elevated some 50 
centimeters above the ground. The test provides information on anxiety 
levels, as expressed in time that the animals venture out on the open arms. It 
also gives information on locomotor activity, expressed in number of 
transitions between the closed arms. The higher the anxiety level, the less 
time will the animal venture out on the open arms. Since this test is 
conceived to be stressful to the animals, we only performed it once, at the 
end of the experimental session. How we performed the tests is described in 
detail in paper I.  
 
Novel object memory 
A common and very strong feature of rodent behavior is a high degree of 
novelty exploration. The object memory test is based on this innate 
motivation to explore novelty (Ennaceur and Delacour 1988) and is a test for 
episodic-like memory in animals. It requires a learning phase, during which 
the animal is presented with two identical objects placed some distance 
apart, so that in order to explore both objects, the animal has to move 
actively across the cage to familiarize with the objects. The learning phase in 
our study lasted two times five minutes, and was separated by a one-minute 
rest in the home cage. The memory phase of the test is done the following 
day by replacing one of the familiar objects with a new one, similar in shape 
and size, but still clearly distinguishable from the familiar object. The theory 
behind this test states that if the animal has a memory of the familiar object, 
it will spend more time exploring the novel object instead of the familiar 
remembered object. Equal time exploring both objects would in the test 
situation indicate a lack of memory of the object from the day before. An 
independent observer analyzed video recordings of the sessions and 
documented the exploration time at each object. The experimental procedure 
is extensively described in the material and methods section in paper II.  
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Radioligand binding 
In paper I we performed radioligand studies to investigate whether 
sevoflurane anesthesia would alter the agonist affinity to nicotinic 
acetylcholine receptor subtypes in the brains of exposed animals. Coronal 
brain sections were incubated with either epibatidine, for labeling of high 
affinity nAChRs; alfa-bungarotoxine, for labeling of low affinity nAChRs; 
or hemicholinium, for labeling of choline uptake sites. Exposure lasted eight 
days, and was followed by image analysis of each ligand to obtain an optical 
density, corresponding to binding to the receptor.  
The work was laborsome but yielded high-resolution images, and 
demonstrated that sevoflurane anesthesia did not alter agonist affinity to 
nicotinic receptors, when investigated 24 hours after exposure. For a 
complete description of the method, please refer to paper I.  
 
Cell culture 
PC12 cells, derived from a rat pheochromocytoma cell line have been 
extensively studied as a model system for cholinergic neurons and also for 
effects of anesthetics (Kress, Muller et al. 1991). In our studies we used 
undifferentiated PC12 cells of subclone I. Prior to experiments we performed 
a characterization of the cells, which revealed that although the 
undifferentiated PC12 cells contained mRNA for both nAChRs and 
mAChRs, only stimulation of muscarinic receptors elicited a measurable 
degree of phosphorylation of the kinases we wanted to study.  Due to this 
finding, we concluded that the cells displayed a functional muscarinic 
profile, and that the nAChRs were not fully operational. It is known that 
differentiation of PC12 cells with nerve growth factor (NGF) causes the 
receptor population to switch to a more neuronal type.  
 
Immunoblotting 
The key experimental method in my experiments has been the 
immunoblotting of cellular protein structures. We have used standard 
techniques in which cells were lysed using SDS-buffer containing ß-
mercaptoethanol and then subsequently sonificated. Samples were loaded 
onto 10% SDS-PAGE gels and separated by gel electrophoresis (60 minutes 
at 200V) before transfer (60 minutes at 105V) onto polyvinylidene fluoride 
(PVDF) membranes (Merck Millipore, Germany). After blocking (5% fat-
free milk in TBST) for 60 minutes, immunoblots were incubated with 
primary antibodies in room temperature for 60 minutes, or at 4°C overnight, 
depending on the type of primary antibody used. After washing in TBST, 
immunoblots were subsequently incubated with secondary HRP-conjugated 
antibodies for 60 minutes at room temperature and developed.  
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Images were captured digitally, and optical density of bands was quantified 
using special software. Optical density of bands representing the protein of 
interest was determined, and values were normalized against the level of a 
housekeeping protein for comparisons, internal loading and quality control. 
For comparisons between exposed and control samples, ratios were 
calculated pair-wise on each membrane. For details, please see the materials 
and methods section in paper III and IV.  
 
PCR 
In our experiments we have bee using two different PCR techniques. In 
paper III we used regular PCR to demonstrate the presence of DNA for the 
various acetylcholine receptors and receptor subtypes. In paper IV we used 
quantitative real time PCR, which allows quantification of the number of 
gene copies present in the cells from the beginning. This allowed for 
comparison and quantification of the different receptors and receptor 
subtypes and their relation to sevoflurane exposure. For details of the 
procedure, see paper III.  
 
Biotinylation assay 
In paper IV, we used a biotinylation assay to determine the population of 
mAChRs localized to the cell membrane versus the population in the cell 
cytoplasm. With this technique, surface proteins are first covalently attached 
to biotin, which is a water-soluble B-complex vitamin (vitamin B7). After 
biotinylation of surface proteins, cells are lysed and the lysate is passed 
through a column coated with Neutravidin, which binds the biotinylated 
proteins. After washing of the column, the biotinylated proteins are eluded 
by adding a strong acid solution, and in the following step, the proteins are 
denatured with SDS and finally analysed using standard immunoblotting 
techniques. This method is described in detail in paper IV.  
 
  
Andreas Wiklund   
 
30 
Table 4: General techniques, methods and materials used in the different papers 
constituting this thesis: 
Method: Paper: 
Open field I, II 
Elevated plus maze I, II 
Novel object memory II 
Radioligand binding (Autoradiography) I 
Cell culture III, IV 
Immunoblotting III, IV 
RT-PCR III 
Quantitative PCR IV 
Biotinylation assay IV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Essentially, all models are wrong, but some are useful  
(George E. P. Box) 
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RESULTS AND COMMENTS:  
PAPER I:  
In paper I we studied how exposure to sevoflurane anesthesia affected 
spontaneous exploratory behavior in young and aged mice, with or without 
cholinergic dysfunction. We demonstrated that both young and aged mice 
with a pre-existing cholinergic dysfunction altered their behavior after 
sevoflurane anesthesia. In mice lacking β2-containing nAChRs, a reduced 
locomotor behavior and an increased exploratory behavior was seen after 
anesthesia. These changes were not observed in mice with a normal 
cholinergic receptor population. Investigations of nAChR density could not 
explain the differences between the groups.  
 
 
Figure 1 from paper I: Locomotor activity and temporo-spatial organization of 
trajectories in young mice.  
(A) Distance moved in the open field before (baseline) and 24 h after anesthesia. 
Anesthesia reduced the distance moved in β2KO mice  (p<0.05) but not in WT mice 
(n.s.).  
(B) Activity in the plus maze expressed as number of transitions between the closed arms 
of the maze. Anesthesia reduced locomotor activity in β2KO mice (p<0.05), but not in 
WT mice (n.s.).  
(C) Spatio-temporal organization of trajectories in the open-field. The number of large 
movements from the peripheral area (PA) across the central area (CA) of the open field is 
indicated by #PA-CA-PA. The conditional probability of a transition from a PA to a CA 
state, i.e. the probability to move from the periphery to the centre, is indicated by %PA-
CA.  
(D) Spatio-temporal organization of trajectories in young mice. All values are compared 
relative to the WT control group, which is set to 100%. Exploration index (explo index) 
provides information on the repartition of fast versus slow movements in the open field 
and is obtained by dividing time spent at slow movement speed with time spent in fast 
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movement speed. Young control β2KO mice differed significantly from young control 
WT regarding exploration index (p<0.01) (D, left), %PA-CA (p<0.01) (D, middle) and 
#PA-CA-PA (p<0.01) (D, right). After sevoflurane anesthesia, exploration index (D, left), 
%PA-CA (D, middle) and #PA-CA-PA (D, right) in young β2KO mice were no longer 
significantly different from young WT mice. No effect of anesthesia on these behavioral 
parameters was demonstrated in young WT mice. Statistical significance for planned 
comparisons between control and anesthesia groups are indicated above the 
corresponding horizontal lines. Symbols within vertical bars indicate statistical 
significance for planned comparison to WT control. (wt=wild type control group (n=20); 
wt+sevo=wild type anesthesia group (n=11); ko=β2 knock out control group (n=18); 
ko+sevo=β2 knock out anesthesia group (n=8) * P<0.05; ** P<0.01; *** P<0.001; - 
P>0.05) 
 
 
Figure 5 from paper I: Autoradiography 
(A) Representative film autoradiograms of  [125I]-epibatidine binding at bregma level -
2.7mm (top), [125I]-α-bungarotoxin binding at bregma level -3.4mm (middle) and [3H]-
hemicholinium binding at bregma level -2.3mm (bottom) of adult wild type mice in 
control group (WT), wild type mice in anesthesia group (WT+sevo), mutant mice in 
control group (KO) and mutant mice in anesthesia group (KO+sevo). Residual binding of 
[125I]-epibatidine to non-β2-containing nAChRs in certain nuclei, such as the fasciculus 
retroflexus (fr), is observed in β2KO mice.  
(B) Quantification of [125I]-α-bungarotoxin binding to low affinity nAChRs. 
(C) Quantification of [125I]-epibatidine binding to high affinity nAChRs.  
(D) [3H]-hemicholinium binding. Values are expressed in arbitrary units as 
median±interquartile range. Exposure to sevoflurane did not alter the density of either 
high or low affinity binding sites in any region, nor did it alter the regional cholinergic 
transmission indexed by the choline transporter. (Amyg=Amygdala; CPut=Caudate 
Putamen; Hippo=Hippocampus; MCx=Motor Cortex; NAc=Nucleus Accumbens; 
wt=wild type control group (n=5); wt+sevo=wild type anesthesia group (n=5); ko=β2 
knock out control group (n=5); ko+sevo=β2 knock out anesthesia group (n=5))  
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PAPER IV:  
In paper IV we investigated if sevoflurane exposure would alter receptor 
localization, quantity or synthesis. Our results demonstrated a sustained 
reduction in acetylcholine-induced ERK 1/2 phosphorylation, as in paper III. 
We could demonstrate that internalization of mAChRs does not occur due to 
sevoflurane exposure alone, and therefore could not explain the attenuated 
response. mRNA for M1 mAChRs was increased after exposure. However, 
this mRNA increase did not affect the receptor protein content, and can thus 
not explain the attenuation of response. On might speculate that an increase 
in mRNA is a compensatory mechanism for a reduction in functional 
receptor proteins, but we have yet no support for this hypothesis. We thus 
concluded that the attenuation of acetylcholine-induced ERK 1/2 
phosphorylation was not likely due to changes in receptor localization or 
receptor quantity. 
 
 
Figure 3 from paper IV: mRNA and protein content in PC12 cells following 
sevoflurane exposure for M1 mAChRs. Shaded bars indicate change in sevoflurane-
exposed cells compared to the non-exposed controls indicated by the white bar. The 
increase in mRNA for M1 mAChRs does not lead to a significant increase in receptor 
protein. Error bars are ±SEM, * indicates p<0.05 from control. N=3-4 in all graphs.  
 
Figure 4 from paper IV: Effects of 
sevoflurane exposure on surface localisation 
of mAChRs. Shaded bars indicate M1 and M4 
mAChRs in sevoflurane-exposed cells 
compared to non-exposed controls. Striped bar 
indicate the negative control Na+/K+ ATPase α-
1, which is a membrane bound protein. The 
black bar indicates the positive control of M4 
mAChRs stimulated with the mAChR selective 
agonist charbachol, which causes 
internalization of half the muscarinic receptor 
population. Error bars are ±SEM, n=3., except 
for positive control in which n=1.  
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DISCUSSION:  
In this thesis we have shown that under certain experimental conditions, 
sevoflurane induces long-lasting alterations both in animal behavior and 
cellular signaling. Our principal aim has been to experimentally address the 
clinical problem of postoperative cognitive dysfunction (POCD) with special 
reference to cholinergic signaling.  
 
The cholinergic hypothesis for cognitive deficits after anesthesia 
After carefully studying the available literature on the matter, we concluded 
that cholinergic neurotransmission would be a highly interesting field to 
further explore, in terms POCD. We founded this hypothesis upon some 
striking similarities between the cognitive deficits seen in Alzheimer’s 
dementia and the descriptions of cognitive dysfunction in the postoperative 
period. As previously mentioned, episodic memory deficits are a hallmark of 
early cognitive impairment, of which some of the features relate to altered 
cholinergic transmission. (Sabri, Kendziorra et al. 2008) As mentioned in the 
introduction, anticholinergic properties of anesthetics are well described, as 
is the potential for anesthetics to act as allosteric modulators on cholinergic 
receptors, both nAChRs and mAChRs.  
 
In this thesis, we have showed that cholinergic status of animals is of 
relevance for the effect of exposure to anesthesia. In paper I, we demonstrate 
that mice lacking the β2-subunit of the nAChR display behavioral alterations 
after anesthesia, while mice with normal cholinergic signaling do not. In 
paper I we speculate on the underlying mechanisms to this observation, and 
conclude that it can either be that a normal cholinergic system protects 
against behavioral alterations, or that a pre-existing cholinergic dysfunction 
could facilitate sevoflurane-induced disturbances in neurotransmission. A 
drawback of using genetically modified animals, which carry the gene 
alteration since conception, is of course the possibility of compensatory 
mechanisms changing the function in other systems, which might affect the 
results.  
 
Re-expression experiments in mice lacking the β2-subunit have shown that 
restoring the receptor population in very localized areas of the brain can 
reverse the behavioral effects (Maskos, Molles et al. 2005). This suggests 
that the effects of sevoflurane on behavior as observed in paper I, might in 
fact relate to changes in very specific neuronal circuits, and do not 
necessarily mirror a global effect on the whole brain. In this context it is 
interesting to note that although previous studies have demonstrated that 
β2KO do not differ in anesthetic requirements and MAC value, we 
demonstrated in paper I that they did take longer time to recover from 
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anesthesia. Here, we noted that the time from discontinuation of sevoflurane 
administration to return of the righting reflex was longer in mice lacking the 
β2-subunit of the nAChR. One possible hypothesis for this effect is that β2-
containing nAChRs play a role in neuronal circuits mediating recovery from 
anesthesia, reflecting the role of the cholinergic system in mediating arousal.  
 
Chronic administration of nicotine reduces hyperactivity in β2KO mice in 
similar, although not necessarily identical ways, as the effect of sevoflurane 
anesthesia in paper I. Hence, we speculate on the possible involvement on 
other nAChRs, notably the α7-nAChR, in the pseudo-normalization of the 
β2KO hyperactive phenotype. With a location on presynaptic nerve terminals 
in modulatory pathways, alterations of α7-nAChR performance could have 
far-reaching consequences by changing the function on several other 
signaling pathways.  
 
Two important conclusions on the cholinergic system in episodic-like 
memory could be drawn from the results in paper II. First, both young and 
aged wild type and β2KO mice that had not been anesthetized displayed 
excellent object memory, suggesting that signaling via receptors containing 
the β2-subunit is not crucial for long-term retention of object memories. 
Secondly, anesthetized wild-type mice and anesthetized β2KO showed 
equally poor object memory retention, indicating that a preexisting nicotinic 
cholinergic deficit did not worsen object memory performance. This in turn 
suggested that other pathways than the nicotinic acetylcholine pathway 
should also be probed in search for the underlying mechanisms of episodic-
like object memory.  
 
In paper III and IV, we demonstrated that even very low concentrations of 
sevoflurane might perturb acetylcholine signaling in cultured cells. This is of 
relevance since it has been shown that residual concentrations of anesthetics 
can remain in the body of patients for extended periods of time, and that the 
rate of elimination drops as the concentration falls. In fact, elimination is 
asymptotic (Lockwood 2010). In our cell culture experiments, we shift focus 
towards the effects on the mAChRs, rather than the nAChRs. One might 
even argue that the effects of sevoflurane on mAChRs are as interesting as 
the effects on α7-nAChR, since these receptors are potential targets for the 
effects observed in β2KO mice after anesthesia.  
 
The contribution of anesthetics versus the effects of systemic inflammation and surgery 
For obvious reasons, large-scale studies in humans with the objective of 
finding the role of anesthetics in POCD are cumbersome. Such studies will 
always have to deal with the effects of surgery and systemic inflammation as 
confounders. Indeed, even studies comparing differences between general 
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and regional anesthesia are obscured by the admixture of sedative doses of 
anesthetics to the group receiving regional anesthesia (Rasmussen, Johnson 
et al. 2003). Still, the contribution of anesthetic drugs to POCD is a question 
of utmost importance. We therefore decided at an early stage that we would 
investigate the role of anesthesia and separate this from the contribution of 
surgical stress or inflammation. The possibility to isolate the role of 
anesthesia from that of the confounders is a very good reason for doing an 
experimental study. Hence, we decided that neither surgery nor blood 
sampling would be performed, to avoid triggering a systemic inflammatory 
reaction in the animals. We also decided upon a combination of 
unconditioned tests: spontaneous exploration of an open field, object 
memory and elevated plus maze. We share the belief that these tests are 
more suitable and possess a higher sensitivity for detecting subtle changes in 
cognitive function. 
  
To reduce stress levels in the animals during the experimental sessions, we 
provided enriched environment in the cages and let the animals get used to 
our presence and handling, by taking care of all the steps in animal handling, 
from changing the bedding in the cages, to feeding and watering the animals. 
In addition, the contribution of stress to the results was controlled for by 
including a sham group of animals, which was subjected to identical 
handling as the anesthesia group with the only exception that they were not 
anesthetized in the anesthesia chamber. During anesthesia, we carefully and 
continuously monitored body temperature and respiratory rate of the 
animals. All anesthetized animals were handled equally and since there are 
no differences in anesthetic requirement between b2KO and wild type, to our 
judgment, the mice did receive an equal anesthetic dose.  
 
With this setup, we were able to detect behavior alterations following 
sevoflurane anesthesia in young and aged mice with a genetically modified 
cholinergic system. These changes were present even though no surgery had 
been done to the animals, nor had we initiated any systemic inflammatory 
response. Mice with a normal cholinergic system did not display any 
behavioral changes in the open field or plus maze tests, suggesting a 
protective role of cholinergic signaling on cognitive changes after anesthesia.  
 
In contrast to others (Terrando, Rei Fidalgo et al. 2010) who have showed 
that anesthesia does not cause memory deficits in wild type mice, our results 
from the episodic-like memory test demonstrated that wild type and mutant 
mice were both affected by sevoflurane anesthesia. This reflects the 
complexity of behavioral testing in animals. First of all, different memory 
tests do not necessarily reflect the same type of memory processing. For 
example, tests involving strong associative conditioning learning are likely 
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to involve brain areas, such as the amygdala, which are not as strongly 
associated with unconditioned exploratory behavior tests. Furthermore, as 
illustrated by our own models, differences in the time allowed for memory 
consolidation may influence the results. Hence, contradictory results 
regarding the effects of anesthetics on memory function are merely an 
indication of the tremendous complexity involved in interpreting and 
designing tests of cognitive function in animals.  
 
In our studies, mice were anesthetized for two hours, spontaneously 
breathing sevoflurane at 2.6% mixed with oxygen. Anesthesia drastically 
lowered the breathing frequency, and although we had controlled for 
hypoxia, other respiratory related physiological changes, such as 
hypercapnia, might have occurred. Nevertheless, since both wild type and 
β2KO were anesthetized according to the same protocol, and since the MAC-
value is not different between wild type and β2KO (Flood, Sonner et al. 
2002), the observed behavioral differences are not likely derived from 
differences in physiological parameters during anesthesia. Sevoflurane at 
2.6% is a concentration that is routine in human anesthesia practice, and was 
chosen to be able to keep the mice spontaneously breathing for two hours. It 
corresponds to approximately 1 minimal alveolar concentration in C57BL6 
mice, and given that no painful stimulus was given to the mice during 
anesthesia, it would probably be considered as a relatively profound level of 
anesthesia. Pilot studies evaluating the sevoflurane concentration revealed 
that higher concentrations lowered the respiratory rate down to levels that 
would risk causing hypoxia in the animals. Temperature regulation in very 
small animals such as mice can be difficult in the laboratory. Anesthesia 
caused a rapid drop in animal body temperature and active warming was 
absolutely necessary. We accomplished this via continuous rectal 
temperature monitoring and a heating lamp. To conclude, animals were 
anesthetized according to an identical protocol. Respiratory rate and body 
temperature was monitored in all animals. No significant difference were 
found between wild type mice and β2KO mice, which suggests that they did 
reach the same depth of anesthesia and thus the same exposure to the 
anesthetic.  
 
Of course, it could be argued that the behavioral effect in β2KO was due to 
incomplete washout of sevoflurane from the brain compartment at 24 hours 
after anesthesia. If this would apply, it still would not explain the differences 
between wild type and β2KO mice. However, such an assumption would 
support our reasoning in paper III, in which we speculate that the effects on 
acetylcholine induced phosphorylation on ERK 1/2 is actually due to 
residual sevoflurane in the medium.  
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The effect of age.  
Since age is one of the risk factors most clearly associated to POCD, we 
wanted to investigate the effect of age in our animal models. Hence, we 
included not only young mice between 3-4 months of age, but also elderly 
mice between 15-18 months of age, which for C57BL/6 mice is a 
considerable age. Previous studies in animals have demonstrated that high 
age increases the risk for cognitive alterations after anesthesia (Culley, 
Baxter et al. 2003; Culley, Baxter et al. 2004; Crosby, Culley et al. 2005).  
 
Prior to the experiments, we thus assumed that aged mice would be more 
susceptible to the effects of anesthesia, and that this would be even more 
obvious in the β2KO group. Instead, the characteristic phenotype of β2KO-
mice became attenuated with increasing age, maybe associated with the 
accelerated aging of these animals. In paper I we therefore we proposed that 
aging itself had an effect on hyperactivity in β2KO-mice, and that this would 
be a consequence of the accelerated aging observed in these animals.  
 
For a memory to become a long-term memory, it requires encoding, which is 
done during the consolidation phase. Interfering with memory consolidation 
will affect the long-term memory storage. In paper I, the first open field 
session was performed 24 hours before anesthesia and the second was done 
24 hours after anesthesia. For this test, animals thus had 24 hours to 
consolidate the memory of the open field, and the results showed that all 
groups displayed habituation from session I to session II. Habituation in this 
context, is reduced exploratory activity, and can be interpreted as long-term 
memory of the test apparatus.  
 
On the other hand, this time frame was radically different for the object 
memory test, evaluating the episodic-like memory. Here, the learning 
sessions were performed immediately before induction of anesthesia, 
allowing only one minute between the end of the learning session and the 
induction of anesthesia. Testing of object memory was performed 24 hours 
after anesthesia, as for the open field test. While all animals, irrespective of 
age or genotype, showed habituation in the open field, only the control 
groups showed long-term memory for the objects. As shown in paper II, age 
was not was attenuated in all anesthesia groups, and unaffected in the control 
groups. Here, even the sham groups were affected, indicating that the stress 
of being transferred into the anesthesia chamber might have an influence on 
memory consolidation, in addition to the potential effect of anesthesia.  
 
To conclude the discussion of paper I, we state that sevoflurane anesthesia 
altered exploratory and anxiety-like behavior in both young and aged β2KO 
but not in wild-type mice of any age. It is further possible to argue that an 
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intact cholinergic system seems to protect against anesthesia-induced 
behavioral changes, as well as age-related changes.  
 
An important conclusion on the influence of age in episodic-like memory 
can be drawn from the results in paper II. Here, both young and aged wild 
type and β2KO mice that had not been anesthetized displayed excellent 
object memory, suggesting that signaling via receptors containing the β2-
subunit is not crucial for long-term retention of object memories. It also 
shows that both wild type and β2KO mice have preserved object memory 
even in senescence. 
 
Long-lasting effects of anesthetics on cellular signaling 
It has previously been described that volatile anesthetics have profound and 
long-lasting effects on various intracellular signaling pathways (Culley, 
Yukhananov et al. 2006; Sekine, Matsumoto et al. 2006; Kalenka, Gross et 
al. 2010). In this thesis, we show that under certain conditions, anesthesia 
can induce effects both on behavior and in cellular function. There might be 
several explanations to this, and an obvious reason is that there is residual 
anesthetic drug affecting signaling pathways. It has been debated that the 
accumulation of anesthetics in the body of patients can be quite considerable 
during a normal anesthesia, and that elimination takes longer time than 
expected.  
 
Measuring acetylcholine-induced phosphorylation of ERK 1/2 provided 
information on gross intracellular effects, and allowed for characterization of 
the exposure-effect relation. The gain in sensitivity for sevoflurane-induced 
changes in signaling pathways simultaneously reduced the possibility to 
identify the exact location of the effect. A great number of intracellular 
signaling pathways converge to ERK 1/2. There is also a considerable 
crosstalk between signaling pathways, making it virtually impossible to 
control for all the possible intermediary factors leading to a particular 
cellular response. Since phosphorylation of ERK 1/2 can be achieved in 
many ways, one must be very cautious in assigning a specific pathway to an 
observed effect.  
 
This problem was addressed in the following way: To ascertain that the 
signal obtained from phosphorylation of ERK 1/2 was a specific muscarinic 
signal, we stimulated cells both with selective muscarinic receptor agonists, 
oxotremorine, and nicotinic receptor agonists, nicotine. These experiments 
showed a clear muscarinic receptor mediated phosphorylation of ERK 1/2, 
and an absent nicotinic response. In addition, we performed quantitative 
PCR analysis to determine the relative distribution of mAChRs, which 
showed predominance for the M1 and the M4 subtypes.  
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Due to the complicated relationship between anesthetic potency and 
temperature, we performed all experiments at 37°C. A comparison between 
acetylcholine-induced phosphorylation of ERK 1/2 in exposed and non-
exposed cell cultures revealed a distinct and sustained attenuation of ERK 
1/2 phosphorylation in sevoflurane-exposed cultures. The attenuation of 
acetylcholine-induced phosphorylation of ERK 1/2 persisted more than two 
hours after exposure, and was not restored to control levels until six hours 
after exposure.  
 
In contrast to the sustained effects on ERK 1/2, sevoflurane exposure 
induced a transient phosphorylation of AKT. Such effects on AKT from 
anesthetic exposure are previously described, and are considered to be of 
relevance to the pharmacological preconditioning effects seen in 
cardiomyocytes. Albeit transient, it is possible that phosphorylation of AKT 
might still have long-lasting effects on gene transcription, not measured in 
this study. Instead, the conclusions of paper III were that sevoflurane 
exposure affects cellular intracellular signaling differentially for ERK1/2 and 
for AKT. While sevoflurane exposure induced a sustained attenuation in 
acetylcholine-induced ERK 1/2 phosphorylation, it caused a transient 
increase in phosphorylation of AKT. 
 
Paper IV was designed as an attempt to pinpoint the location for the effect 
observed in paper III. Here, we chose to start from the cellular surface, at the 
level of the muscarinic receptors. The aim of was to investigate if 
sevoflurane exposure would alter the mAChR population on the cell surface. 
An acute internalization of mAChRs during sevoflurane exposure followed 
by a gradual restoration of surface receptors could possibly explain the 
dynamics in paper III. Therefore, a biotinylation assay was chosen to 
quantify surface bound receptors. We also quantitatively measured 
messenger RNA for the two most abundant muscarinic receptors, the M4 and 
the M1, to investigate possible alterations in gene transcription. Indeed, 
sevoflurane exposure increased levels of M1 mRNA, but this was not 
reflected in increased receptor protein content. Protein levels were assessed 
using standard immunoblotting techniques. The results showed that while 
stimulation with a muscarinic agonist caused internalization of mAChRs, 
there was no difference in surface bound muscarinic receptor protein 
between sevoflurane exposed and control cell cultures. Hence, we concluded 
that neither mAChR internalization, nor altered mAChR receptor content, 
would likely explain the attenuation of acetylcholine induced ERK 1/2 
phosphorylation following sevoflurane exposure. 
  Conclusions 
 
 43
CONCLUSIONS:  
The overall conclusion from the results of this thesis is that under certain 
experimental conditions, sevoflurane induces long-lasting alterations both in 
animal behavior and cellular signaling. This is based on the following:  
 
We conclude that sevoflurane anesthesia alters exploratory and anxiety-like 
behavior in mice lacking β2-containing nAChRs. We suggest that brain 
circuits involved in organization of locomotor behavior or anxiety should be 
further investigated, as should the possible pharmacologic modulation of the 
effect and the cellular origin.  
 
Furthermore, we have shown that post-training exposure to anesthesia causes 
similar long-term object memory impairment in both wild type and mutant 
mice lacking β2-containing nAChRs. This effect is seen when considering 
the combination of anesthesia and handling of the animals. We have shown 
that signaling through β2-containing nAChRs is not critically involved in 
long-term object memory in mice. In our results, we did not find any effect 
of age on temporospatial or object memory in wild type mice.  
 
In our cellular model, we have shown that sevoflurane exposure perturbs 
signaling in a dual manner. On one hand, sevoflurane causes a sustained 
attenuation of acetylcholine-induced ERK 1/2 phosphorylation that persists 
even at sevoflurane concentrations close to detection level. On the other 
hand, AKT phosphorylation is increased two-fold during sevoflurane 
exposure, with a rapid return to baseline values after exposure.  
 
We have also shown that the mechanism behind the attenuation of 
acetylcholine-induced ERK 1/2 phosphorylation is not likely related to 
alterations in mAChR gene expression, receptor protein content or amount 
of receptors on the cell surface.  
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